At close: 2:00:22 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 1 |
| Avg. Estimate | 0 | 0 | 3.14 | 2.33 |
| Low Estimate | 0 | 0 | 2.8 | 2.33 |
| High Estimate | 0 | 0 | 3.48 | 2.33 |
| Year Ago EPS | -- | -- | -1.18 | 3.14 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 76.09M | 55.76M |
| Low Estimate | -- | -- | 38.8M | 31M |
| High Estimate | -- | -- | 98.48M | 86.27M |
| Year Ago Sales | -- | -- | 2.23M | 76.09M |
| Sales Growth (year/est) | -- | -- | 3,316.85% | -26.73% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 3.14 | 2.33 |
| 7 Days Ago | 0 | 0 | 3.14 | 2.33 |
| 30 Days Ago | 0 | 0 | 3.14 | 2.33 |
| 60 Days Ago | 0 | 0 | 3.14 | 2.33 |
| 90 Days Ago | 0 | 0 | 3.4 | 2.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OSE.PA | -- | -- | 366.19% | -25.75% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
ADOC.PA Adocia SA
5.98
+1.01%
ALCOX.PA Nicox S.A.
0.2830
-2.41%
ALVAL.PA Valbiotis SA
1.3860
+1.17%
TNG.PA Transgene SA
0.6950
-0.71%
DBV.PA DBV Technologies S.A.
0.6190
-1.28%
ALSEN.PA Sensorion SA
0.6160
-0.32%
NURPF Neuren Pharmaceuticals Limited
7.87
0.00%
VICO.ST Vicore Pharma Holding AB (publ)
7.71
-1.91%
ALTME.PA TME Pharma N.V.
0.0775
+3.89%
ULTI.OL Ultimovacs ASA
2.4450
-4.12%